Poging GOUD - Vrij

Congress: Survival or revival

Business Standard

|

October 26, 2024

Congress is silently acknowledging it overread the verdict of the last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand

- SHEKHAR GUPTA

What if I said the two worst things to happen to the Congress in the past two decades are its victory of sorts in 2004 and the 99 in 2024? You'd ask me to get my head examined. Before that, however, please hear me out.

The Congress party is in the news, obviously because of the complex seat-sharing talks in Maharashtra and Jharkhand. It has made one wise decision outside these states, by leaving all nine by-elections in Uttar Pradesh to its INDIA bloc partner, the Samajwadi Party (SP). In victory or defeat, in coalition or by itself, the party continues to confound both its supporters and rivals.

To understand how the party got here, we need to start with 2004. The fact is, neither snatching defeat from the jaws of victory nor its reverse applies to the Congress in the national picture. That's why the two worst things to happen to the Congress in these 20 years have been near-things that it conveniently declared as victories.

The first was a score of 145 in the 2004 Lok Sabha elections, just seven ahead of Vajpayee's Bharatiya Janata Party (BJP). With this, Sonia Gandhi, helped along by the Left's historic peak of 59 seats, was able to put together the United Progressive Alliance (UPA). It ruled for a decade, improving its tally in 2009. The second was the 99 it scored in the 2024 general elections, as part of the 234 for the INDIA coalition it putatively headed.

If you were a Congress loyalist, you'd hail each as a great success and hail the Gandhis as BJP-slayers. If you were an opponent, you'd say 2004 was a fluke and 2024 was still a defeat, the third successive time the party failed to reach triple figures.

Why would a commentator then call these two the worst things to happen to the Congress? Why, when one brought it a decade in power, and the other cut Narendra Modi to size?

MEER VERHALEN VAN Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size